X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

URGN

Closed

Urogen Pharma Ltd

10.76
-0.28 (-2.54%)
Last Update: 28 Dec 2024 00:00:00
Yesterday: 11.04
Day's Range: 10.6 - 11.1604
Send
When Written:
 
9.28
UroGen Pharma Ltd is a clinical-stage biopharmaceutical company that focuses on developing and commercializing novel therapies for urological and oncological diseases. The company's lead product candidate is UGN-101, a drug-device combination designed to treat low-grade upper tract urothelial cancer (LG UTUC), a type of cancer that affects the lining of the urinary tract. UroGen's technology platform, called RTGel, enables the sustained release of drugs directly into the bladder or upper urinary tract, providing a targeted and localized treatment approach. The company is also developing other product candidates for the treatment of bladder cancer, prostate cancer, and other urological disorders. UroGen Pharma Ltd was founded in 2004 and is headquartered in New York City.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:18.227.0.21
X